米上院議員、バイオ兵器懸念の高まりを受け合成DNA販売の規制に動く
Two U.S. senators introduced a bill to impose federal screening rules on synthetic DNA sales, requiring providers to vet
FDA、Regenxbioの遺伝子治療を一時停止 小児の脳腫瘍発生で株価下落
The U.S. FDA halted clinical trials of Regenxbio’s gene therapies RGX-111 and RGX-121 after a child in the RGX-111 study